Methotrexate for rheumatoid arthritis patients who are on hemodialysis
- First Online:
- Cite this article as:
- Al-Hasani, H. & Roussou, E. Rheumatol Int (2011) 31: 1545. doi:10.1007/s00296-011-2041-5
- 546 Downloads
Methotrexate (MTX) can be toxic to patients suffering from end stage renal disease (ESRD) on hemodialysis even at low doses. This increase in toxicity is more notable in terms of bone marrow suppression in the form of pancytopenia. Many methods of elimination including dialysis itself have been proven ineffective, and alternate treatments with anti-TNF alpha blockers can be considered.